Pliant Therapeutics
@pliantrx
We are breaking new ground in the treatment of fibrosis. 2023 Best Places to Work. $PLRX
ID: 4890499717
https://pliantrx.com/ 11-02-2016 01:18:32
281 Tweet
485 Followers
142 Following
Throughout December members of our team will be participating in events hosted by Evercore ISI, Citi, Piper Sandler and Oppenheimer & Co. Inc. to share our progress with the investment community. More details: ir.pliantrx.com/news-releases/…
This Thanksgiving week, we’re reminded of the incredible community that surrounds us. This year, Team Pliant joined Pulmonary Fibrosis Foundation Walks nationwide to raise funds and awareness for pulmonary fibrosis. Together, we're working to bring hope to patients impacted by fibrotic diseases.
We’re proud to be working with Black Health Matters in support of BEACON-IPF initiatives aimed to enhance diversity in our clinical trials & expand outreach to the Black and African American communities. Looking forward to the year ahead. Learn more: beaconipf.com
Giving back is part of our core at Pliant & we’re delighted to support HealthRIGHT 360’s Women’s Recovery Association program by donating holiday self-care kits. We recognize the importance of making a difference in our communities! Learn more: healthright360.org #givingback
Join our CEO, Dr. Bernard Coulie, at the 43rd Annual J.P. Morgan Healthcare Conference with a review of our 2024 achievements and 2025 milestones in a presentation on Tuesday, January 14 at 1:30 p.m. PT. #JPM25 #JPMHC25 ir.pliantrx.com/news-releases/…
Today, we announced three upcoming presentations at the American Thoracic Society's 2025 International Conference, taking place May 16-21 in San Francisco, California. Read the press release here: ir.pliantrx.com/news-releases/… #ATS2025 American Thoracic Society (ATS)
A productive week at the American Thoracic Society (ATS)'s 2025 International Conference featured pre-clinical and clinical work from our teams. Learn more and access the presentation and posters ir.pliantrx.com/news-releases/… #ATS2025